Liver-specific expression of transcriptionally active srebp-1c is associated with fatty liver and increased visceral fat mass

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Knebel, Birgit ^a   Haas, Jutta ^b   Hartwig, Sonja ^a   Jacob, Sylvia ^a   Köllmer, Cornelia ^a   Nitzgen, Ulrike ^a   Muller Wieland, Dirk ^b   Kotzka, Jorg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; MONOUNSATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; ACYL COENZYME A DESATURASE; ACYLTRANSFERASE; CYTOKINE; FATTY ACID ELONGASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CONTROLLED STUDY; FATTY LIVER; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ADIPOCYTE; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; INTRAABDOMINAL FAT; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SECRETION; TRANSGENIC MOUSE;

ACETYLTRANSFERASES; ADIPOCYTES; ADIPOSITY; ANIMALS; BODY COMPOSITION; CYTOKINES; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPOGENESIS; LIVER; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION, GENETIC;

EID: 84857383028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031812     Document Type: Article

References (66)

1. Unger RH, (2002) Lipotoxic diseases. Annu Rev Med 53: 19-36.
2. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin. Invest 115: 1343-1351.
3. Choi SS, Diehl AM, (2008) Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol 19: 295-300.
4. Musso G, Gambino R, Cassader M, (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid 48: 1-26.
5. Parks ER, Krauss CM, Neese PR, Hellerstein M, (1999) Effects of a low-fat, high carbohydrate diet on VLDL-triglyceride assembly, production and clearance. J Clin. Invest 104: 1087-1096.
6. Parks E, (2002) Dietary carbohydrate's effect on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br J Nutr 87: S247-S253.
7. Aarsland A, Chinkes D, Wolfe RR, (1997) Hepatic and whole body fat synthesis in humans during carbohydrate overfeeding. Am J Clin. Nutr 65: 1174-1182.
8. Parks EJ, Skokan LE, Timlin MT, Dingfelder CS, (2008) Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 138: 1039-1046.
9. Schwarz JM, Linfoot P, Dare D, Aghajanian K, (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77: 43-50.
10. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, et al. (2000) Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res 41: 595-604.
11. Chong MF, Hodson L, Bickerton AS, Roberts R, Neville M, et al. (2008) Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin. Nutr 87: 817-823.
12. Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, et al. (2009) High fat feeding induces hepatic fatty acid elongation in mice. PLoS ONE 4: e6066.
13. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, et al. (2005) Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54: 1907-1913.
14. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, et al. (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48: 993-999.
15. Hernandez C, Lin JD, (2009) A sweet path to insulin resistance through PGC-1b. Cell Metab 9: 215-216.
16. Kantartzis K, Schick F, Häring HU, Stefan N, (2010) Environmental and genetic determinants of fatty liver in humans. Dig Dis 28: 169-178.
17. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci USA.100: 12027-12032.
18. Brewer M, Lange D, Baler R, Anzulovich A, (2005) SREBP-1 as a transcriptional integrator of circadian and nutritional cues in the liver. J Biol Rhythms 20: 195-205.
19. Shimomura I, Bashmakov Y, Horton JD, (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274: 30028-30032.
20. Strable MS, Ntambi JM, (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 45: 199-214.
21. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
22. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD, (1998) Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273: 35299-35306.
23. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, et al. (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99: 846-854.
24. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, et al. (2008) SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 21: 507-511.
25. Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, et al. (2008) Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 38: 1122-1129.
26. Ferré P, Foufelle F, (2007) SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 68: 72-82.
27. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS, (1995) Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J Biol Chem 270: 29422-29427.
28. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS, (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99: 838-845.
29. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, et al. (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75: 187-197.
30. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
31. Brown MS, Goldstein JL, (2009) Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 50: S15-S27.
32. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB, (2008) SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19: 65-73.
33. Engelking LJ, Liang G, Hammer RE, Takaishi K, Kuriyama H, et al. (2005) Schoenheimer effect explained-feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J Clin Invest 115: 2489-2498.
34. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, et al. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120: 261-273.
35. Sampath H, Miyazaki M, Dobrzyn A, Ntambi JM, (2007) Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 282: 2483-2493.
36. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6: 77-86.
37. Gregor MF, Hotamisligil GS, (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415-445.
38. Tilg H, Hotamisligil GS, (2006) Nonalcoholic fatty liver disease: cytokine- adipokine interplay and regulation of insulin resistance. Gastroenterology 131: 934-945.
39. Ndumele CE, Nasir K, Conceiçao RD, Carvalho JA, Blumenthal RS, Santos RD, (2011) Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler Thromb Vasc Biol 31: 1927-32.
40. Izban MG, Papaconstantinou J, (1989) Cell-specific expression of mouse albumin promoter. Evidence for cell-specific DNA elements within the proximal promoter region and cis-acting DNA elements upstream of -160. J Biol. Chem 264: 9171-9179.
41. Lomvardas S, Thanos D, (2002) Opening chromatin. Mol Cell 2002 9: 209-211.
42. Nahon JL, (1987) The regulation of albumin and alpha-fetoprotein gene expression in mammals. Biochimie 69: 445-459.
43. Trojan J, Naval X, Johnson T, Lafarge-Frayssinet C, et al. (1995) Expression of serum albumin and of alphafetoprotein in murine normal and neoplastic primitive embryonic structures. Mol Reprod. Dev 42: 369-378.
44. Hanson RW, Reshef L, (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem 66: 581-611.
45. Stefan N, Peter A, Cegan A, Staiger H, Machann J, et al. (2008) Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 51: 648-656.
46. Wendel AA, Li LO, Li Y, Cline GW, Shulman GI, et al. (2010) Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59: 1321-1329.
47. Olofsson SO, Stillemark-Billton P, Asp L, (2000) Intracellular assembly of VLDL: two major steps in separate cell compartments. Trends Cardiovasc Med 10: 338-345.
48. Björkegren J, Beigneux A, Bergo MO, Maher JJ, Young SG, (1999) Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury. J Clin Invest 103: 1287-1298.
49. Raabe M, Véniant MM, Sullivan MA, Zlot CH, Björkegren J, et al. (2002) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Biol Chem 277: 5476-5483.
50. Minehira K, Young SG, Villanueva CJ, Yetukuri L, Oresic M, et al. (2008) Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J Lipid Res 49: 2038-2044.
51. Shah A, Mehta N, Reilly MP, (2008) Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr 32: 638-644.
52. Meissburger B, Stachorski L, Röder E, Rudofsky G, Wolfrum C, (2011) Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 54: 1468-1479.
53. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, et al. (2003) Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278: 11888-11896.
54. Herbach N, Rathkolb B, Kemter E, Pichl L, Klaften M, et al. (2007) Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes 56: 1268-1276.
55. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737.
56. Moloney F, Toomey S, Noone E, Nugent A, Allan B, et al. (2007) Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56: 574-582.
57. Potenza MA, Marasciulo FL, Tarquinio M, Quon MJ, Montagnani M, (2006) Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance. Diabetes 55: 3594-3603.
58. Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, et al. (2004) Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation 110: 3259-3269.
59. Heikkinen S, Argmann CA, Champy MF, Auwerx J, (2007) Evaluation of glucose homeostasis. Curr Protoc Mol Biol. Chapter 29: Unit 29B.3.
60. Mather K, (2009) Surrogate measures of insulin resistance: of rats, mice, and men. Am J Physiol Endocrinol Metab 296: 398-399.
61. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, et al. (2009) Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 58: 203-208.
62. Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ, (2008) Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 14: 2474-2486.
63. Morin P Jr, Storey KB, (2009) Mammalian hibernation: differential gene expression and novel application of epigenetic controls. Int J Dev Biol 53: 433-442.
64. Pinkert CA, Ornitz DM, Brinster RL, Palmiter RD, (1987) An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev 3: 268-276.
65. Kotzka J, Knebel B, Avci H, Jacob S, Nitzgen U, et al. (2010) Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes. Atherosclerosis 213: 156-165.
66. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, et al. (2003) Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100: 14211-14216.